Cardio Diagnostics Holdings Inc

Research Cardio Diagnostics Holdings Inc (CDIO) on Bullrun: market cap USD 6.16M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCDIO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 6.16M
• Financial periodFY2025
• RevenueUSD 14.83K
• Revenue growth-57.5%
• Net income-USD 6.50M
• Free cash flow-USD 5.91M

Valuation Snapshot

latest market cap is USD 6.16M.

About Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease;

Frequently asked questions

What is Cardio Diagnostics Holdings Inc's market cap?

Cardio Diagnostics Holdings Inc's market capitalization is USD 6.16M.

What does Cardio Diagnostics Holdings Inc do?

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks;